Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?

Santini V; Schemenau J; Levis A; Balleari E; Sapena R; Adès L; Guerci A; Beyne-Rauzy O; Gourin MP; Cheze S; Stamatoullas A; Sanna A; Gioia D; Cametti G; Ferrero D; Raffoux E; Rose C; Poloni A; Prebet T; Legros L; Natarajan-Amé S; Fenaux P; Germing U; Dreyfus F; Park S.